[1] BRAY F,LAVERSANNE M,SUNG H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA-Cancer J Clin,2024,74(3):229-263.
[2] GRADISHAR WJ,MORAN MS,ABRAHAM J,et al.Breast cancer,version 3.2024,NCCN clinical practice guidelines in oncology[J].J Natl Compr Canc NE,2024,22(5):331-357.
[3]DE ROSE F,CARMEN DE SANTIS M,LUCIDI S,et al.Dose constraints in breast cancer radiotherapy.A critical review[J].Radiother Oncol,2024,202:110591.
[4]MADUME R,SINGH RAIT J.Is breast conservation surgery feasible in ipsilateral cancer recurrence with previous radiotherapy[J].J Global Med,2024,4(S1):e191.
[5]BALAJI K,SUBRAMANIAN B,YADAV P,et al.Radiation therapy for breast cancer:Literature review[J].Med Dosim,2016,41(3):253-257.
[6]MISHRA SS,NANDA S,AHIRWAR MK,et al.Advancing precision in post-mastectomy chest wall radiotherapy:A comparative dosimetric analysis of volumetric-modulated arc therapy (VMAT) and intensity-modulated radiotherapy (IMRT) based on institutional experience[J].Cureus,2023,15(5):e38464.
[7]KARPF D,SAKKA M,METZGER M,et al.Left breast irradiation with tangential intensity modulated radiotherapy (t-IMRT) versus tangential volumetric modulated arc therapy (t-VMAT):trade-offs between secondary cancer induction risk and optimal target coverage[J].Radiat Oncol,2019,14(1):156.
[8] LIU H,CHEN X,HE Z,et al.Evaluation of 3D-CRT,IMRT and VMAT radiotherapy plans for left breast cancer based on clinical dosimetric study[J].Comput Med Imaging Graph,2016,54:1-5.
[9] MANDAL A,ASTHANA AK,PRADHAN S,et al.Search of an ideal location of isocenter in intensity-modulated radiotherapy treatment plans:A dosimetrical approach[J].J Cancer Res Ther,2019,15(1):211-215.
[10]国家癌症中心/国家肿瘤质控中心.乳腺癌术后放疗靶区勾画和计划设计指南[J].中华放射肿瘤学杂志,2022,31(10):863-878.National Cancer Center/National Center for Cancer Quality Control.Guidelines for target delineation and planning design of postoperative radiotherapy for breast cancer[J].Chinese Journal of Radiation Oncology,2022,31(10):863-878.
[11]郭晨雷,徐英杰,戴建荣.乳腺癌容积调强弧形治疗的射野边界外放方法[J].中华放射肿瘤学杂志,2018,27(9):845-849.GUO CL,XU YJ,DAI JR.Margin expansion for treatment field of volumetric modulated arc therapy for breast cancer[J].Chinese Journal of Radiation Oncology,2018,27(9):845-849.
[12]KAUSAR M,GURJAR O,BAGDARE P,et al.Dosimetric analysis of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for chest wall irradiation in breast cancer patients[J].J Radiother Pract,2015,15(1):30-37.
[13]AlSAIHATY Z,ABDUL MANAN H,SABARUDIN A,et al.Hybrid treatment planning for chest wall irradiation utilizing three-dimensional conformal radiotherapy (3DCRT),intensity-modulated radiation therapy (IMRT),and volumetric modulated arc therapy (VMAT):a systematic review[J].Cureus,2024,16(5):e59583.
[14]郝金龙,曾静,曲芃芃.宫颈癌容积旋转调强计划中射野等中心位置的剂量学影响[J].生物医学工程与临床,2022,26(4):450-454.HAO JL,ZENG J,QU PP.Dosimetric effect of isocenter location on cervical cancer volumetric modulated arc therapy plan[J].Biomedical Engineering and Clinical Medicine,2022,26(4):450-454.
[15]SALTER BJ,FUSS M,SARKAR V,et al.Optimization of isocenter location for intensity modulated stereotactic treatment of small intracranial targets[J].Int J Radiat Oncol,2009,73(2):546-555.
[16]杨海芳,刘建平,王志武,等.多等中心调强计划在双侧乳腺癌放射治疗中的应用[J].中华肿瘤防治杂志,2020,27(19):1548-1553.YANG HF,LIU JP,WANG ZW,et al.Application of intensity-modulated radiation therapy with multi-ISO centers planning method for bilateral breast cancer[J].Chinese Journal of Cancer Prevention and Treatment,2020,27(19):1548-1553.
[17]XIE Y,BOURGEOIS D,GUO B,et al.Comparison of conventional and advanced radiotherapy techniques for left-sided breast cancer after breast conserving surgery[J].Med Dosim,2020,45(4):e9-e16.
[18]HALL EJ,WUU CS.Radiation-induced second cancers:the impact of 3D-CRT and IMRT[J].Int J Radiat Oncol,2003,56(1):83-88.
[19]吴华玲,林清.乳腺癌调强放疗后放射性肺炎的临床和剂量学相关因素分析[J].中国癌症防治杂志,2024,16(3):327-331.WU HL,LIN Q.Analysis of clinical and dosimetric factors related to radiation pneumonitis after intensity-modulated radiotherapy in breast cancer[J].Chinese Journal of Oncology Prevention and Treatment,2024,16(3):327-331.
[20]KONKOL M,SNIATALA P,MILECKI P.Radiation-induced lung injury-what do we know in the era of modern radiotherapy[J].Rep Pract Oncol Radi,2022,27(3):552-565.
[21]KUNDRAT P,REMMELE J,RENNAU H,et al.Inter-patient variability in doses to nearby organs in breast-cancer radiotherapy:inference from anatomic features[J].Radiat Prot Dosim,2019,183(1-2):255-258.
[22]INSKIP PD,STOVALL M,FLANNERY JT.Lung cancer risk and radiation dose among women treated for breast cancer[J].JNCI-J Natl Cancer I,1994,86(13):983-988.
[23]蒲琴,赵彪,袁美芳,等.基于内缘切线拉弧的VMAT在左侧乳腺癌保乳术后放疗中的应用[J].现代肿瘤医学,2024,32(8):1480-1485.PU Q,ZHAO B,YUAN MF,et al.Application of volumetric modulated arc therapy based on inner edge tangential arc for left breast cancer patients after breast-conserving surgery[J].Modern Oncology,2024,32(8):1480-1485.
[24]QIU J,ZHANG S,LV B,et al.Cardiac dose control and optimization strategy for left breast cancer radiotherapy with non-uniform VMAT technology[J].Technol Cancer Res T,2021,20:15330338211053752.
[25]陈美琴,周玲,丁叔波.VMAT技术用于乳腺癌改良根治术后放疗患者的剂量学研究[J].现代实用医学,2024,36(10):1359-1362.CHEN MQ,ZHOU L,DING SB.Dosimetry study of VMAT technique in patients with radiotherapy after modified radical surgery for breast cancer[J].Modern Practical Medicine,2024,36(10):1359-1362.
[26]SARDARO A,MCDONALD F,BARDOSCIA L,et al.Dyspnea in patients receiving radical radiotherapy for non-small cell lung cancer:A prospective study[J].Front Oncol,2020,10:594590.
[27]SAIKI H,PETERSEN IA,SCOTT CG,et al.Risk of heart failure with preserved ejection fraction in older women after contemporary radiotherapy for breast cancer[J].Circulation,2017,135(15):1388-1396.
[28]HU J,HAN G,LEI Y,et al.Dosimetric comparison of three radiotherapy techniques in irradiation of left-sided breast cancer patients after radical mastectomy[J].Biomed Res Int,2020,2020:7131590.
[29]WANG R,SHEN J,YAN H,et al.Dosimetric comparison between intensity-modulated radiotherapy and volumetric-modulated arc therapy in patients of left-sided breast cancer treated with modified radical mastectomy[J].Consort Medicine,2022,101(2):e28427.
[30]AIHARA T,TANAKA S,SAGARA Y,et al.Incidence of contralateral breast cancer in Japanese patients with unilateral minimum-risk primary breast cancer, and the benefits of endocrine therapy and radiotherapy[J].Breast Cancer-Tokyo,2012,21(3):284-291.
[31]中国医师协会放射肿瘤治疗医师分会.乳腺癌放射治疗指南(中国医师协会2020版)[J].中华放射肿瘤学杂志,2021,30(4):321-342.Chinese Medical Doctor Association Radiation Oncologist Branch.Guidelines for radiotherapy of breast cancer (Chinese Medical Doctor Association 2020 edition)[J].Chinese Journal of Radiation Oncology,2021,30(4):321-342.